1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

13 Aug 2021
Admin
News Article

China Approves Gc Pharmas Greengene F As A Therapy To Treat Haemophilia A

China National Medical Products Administration (Nmpa) Has Approved Gc Pharma'S Greengene F (Beroctocog Alfa) [Recombinant Human Coagulation Factor Viii For Injection] For The Control And Prophylaxis Of Bleeding Episodes In Individuals With Haemophilia A.The Collaboration Will Facilitate Gc China, A Leading Plasma-Derived Haemophilia Products Provider In China And Also A Gc Pharma&Rsquo;S Affiliate Company, Greengene F Will Be Available In China Within The First Half Of Next Year.Greengene F Was Initially Approved By The Korean Health Authority In 2010 For Control And Prevention Of Bleeding Episodes In Patients With Haemophilia A."The Approval Of Greengene F In China Marks An Important Milestone For Gc Pharma And Supports Our Ongoing Commitment To Treating Patients Living With Rare Disorder," Said Ec Huh, Ph.D., President Of Gc Pharma.In The Pivotal Phase Iii Clinical Trial Conducted In China, Which Served As The Foundation For The Approval, Greengene F Demonstrated Efficacy In Treating Hemophilia Patients. About 80 Percent Of Patients Showed Improvement In Symptoms Within 8 Hours After A Single Injection, Meeting Its Primary Efficacy Endpoints Of Hemostasis And Bleeding Prevention. The Trials Also Met Of Its Secondary Endpoints With 94 Percent Reduction Of Annual Bleeding And Annual Joint Bleeding Rates.The Trial Also Included Patient-Reported Quality Of Life (Qol) Metrics. Patients Treated With &Lsquo;Greengene F&Rsquo; Reported An Improvement In Hemophilia-Related Symptoms Compared To Before Receiving The Treatment.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!